Phio Pharmaceuticals CEO Robert J. Bitterman forfeited 68,550 shares at $1.03 per share on September 11, leaving him with 362,871 shares. The transaction represented about 15.9% of his prior shareholding, giving investors a precise measure of the change in his direct ownership.

Key Highlights

  • The transaction was classified under SEC code F, which denotes tax-related withholding.
  • Robert J. Bitterman held 362,871 Phio Pharmaceuticals shares after the transaction.
  • The forfeited shares represented about 15.9% of his prior shareholding.

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) Chairman, President and CEO Robert J. Bitterman forfeited 68,550 shares at $1.03 per share on September 11, 2026.

Bitterman Owned 362,871 Shares

Bitterman held 362,871 shares after the transaction. His listed roles at Phio Pharmaceuticals Corp. are chairman, president and CEO. The transaction was recorded using SEC transaction code F, a classification for tax-related withholding. The forfeited shares represented about 15.9% of Bitterman’s prior shares holding.